Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Linagliptin as potential treatment for uremic calcification

Oct. 3, 2014

Higher serum CRTC3 associated with poorer metabolic profile in prepubertal children

Oct. 3, 2014

BI-415756, a novel potent CETP inhibitor for the treatment of cardiovascular diseases

Oct. 3, 2014

BTA-C585 shows excellent pharmacokinetic and safety profile in animal studies

Oct. 3, 2014

XenoPort presents pharmacokinetic data for XP-23829

Oct. 3, 2014

Phase I/II first-in-human results presented for lucitanib

Oct. 3, 2014

Novel candidates for neuropathic pain prepared at Nippon Chemiphar

Oct. 2, 2014

Model of autoimmune optic neuritis used to assess new treatment strategy

Oct. 2, 2014

Phase II data presented in patients with CMV and adenovirus resistance profiles

Oct. 2, 2014

Preclinical profile of basimglurant described

Oct. 2, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...